Quick Answer
Silo Pharma, Inc. reported Stockholders Equity of $6.31 million for fiscal year 2025.
Silo Pharma, Inc. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $6.31M | +25.3% |
| 2024 | $5.03M | -18.5% |
| 2023 | $6.18M | -40.3% |
| 2022 | $10.34M | +14.1% |
| 2021 | $9.06M | +607.6% |
| 2020 | $1.28M | +5694.5% |
| 2019 | -$22.9K | -105.6% |
| 2018 | $407.4K | -66.1% |
| 2017 | $1.20M | +42.1% |
| 2016 | $846.5K | -52.7% |
| 2013 | $1.79M | +4442.1% |
| 2012 | -$41.2K | -2256.6% |
| 2011 | -$1.7K | -103.7% |
| 2010 | $47.5K | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $5.01M | -26.1% | +1.9% |
| June 30, 2025 | $4.92M | -17.5% | +22.6% |
| March 31, 2025 | $4.01M | -24.2% | -20.3% |
| December 31, 2024 | $5.03M | -18.5% | -25.8% |
| September 30, 2024 | $6.78M | -9.5% | +13.8% |
| June 30, 2024 | $5.96M | -28.2% | +12.6% |
| March 31, 2024 | $5.29M | -44.0% | -14.3% |
| December 31, 2023 | $6.18M | -40.3% | -17.6% |
- Silo Pharma, Inc. showed an increase of +25.3% in Stockholders Equity compared to the prior fiscal year.
- Over the 2010–2025 period, Silo Pharma, Inc.’s stockholders equity has grown by 13180.2% (from $47.5 thousand to $6.31 million).
- The most recent figure is from Silo Pharma, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 27, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: